Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm S-141 86, Sweden;
J Immunol. 2014 May 15;192(10):4685-96. doi: 10.4049/jimmunol.1302253. Epub 2014 Apr 16.
Viral escape from HIV-1-specific CD8(+) T cells has been demonstrated in numerous studies previously. However, the qualitative features driving the emergence of mutations within epitopes are still unclear. In this study, we aimed to distinguish whether specific functional characteristics of HLA-B5701-restricted CD8(+) T cells influence the emergence of mutations in high-risk progressors (HRPs) versus low-risk progressors (LRPs). Single-genome sequencing was performed to detect viral mutations (variants) within seven HLA-B5701-restricted epitopes in Gag (n = 4) and Nef (n = 3) in six untreated HLA-B5701 subjects followed from early infection up to 7 y. Several well-characterized effector markers (IFN-γ, IL-2, MIP-1β, TNF, CD107a, and perforin) were identified by flow cytometry following autologous (initial and emerging variant/s) epitope stimulations. This study demonstrates that specific functional attributes may facilitate the outgrowth of mutations within HLA-B5701-restricted epitopes. A significantly lower fraction of IL-2-producing cells and a decrease in functional avidity and polyfunctional sensitivity were evident in emerging epitope variants compared with the initial autologous epitopes. Interestingly, the HRPs mainly drove these differences, whereas the LRPs maintained a directed and maintained functional response against emerging epitope variants. In addition, LRPs induced improved cell-cycle progression and perforin upregulation after autologous and emerging epitope variant stimulations in contrast to HRPs. The maintained quantitative and qualitative features of the CD8(+) T cell responses in LRPs toward emerging epitope variants provide insights into why HLA-B*5701 subjects have different risks of HIV-1 disease progression.
先前的众多研究已经证实,HIV-1 特异性 CD8(+) T 细胞发生了病毒逃逸。然而,导致表位内突变出现的定性特征仍不清楚。在这项研究中,我们旨在区分 HLA-B5701 限制性 CD8(+) T 细胞的特定功能特征是否会影响高危进展者 (HRP) 与低危进展者 (LRP) 中突变的出现。对 6 名未经治疗的 HLA-B5701 个体进行了从早期感染到 7 年的随访,通过对 Gag (n = 4) 和 Nef (n = 3) 中 7 个 HLA-B5701 限制性表位内的病毒突变 (变体) 进行了单基因组测序,以检测 HLA-B5701 限制的表位内的病毒突变 (变体)。通过流式细胞术,对初始和新兴变体/表位刺激后的自体 (初始和新兴变体/表位) 进行了多种特征明确的效应标记物 (IFN-γ、IL-2、MIP-1β、TNF、CD107a 和穿孔素) 的鉴定。这项研究表明,特定的功能属性可能有助于 HLA-B5701 限制性表位内的突变出现。与初始自体表位相比,新兴表位变体中产生 IL-2 的细胞比例显著降低,功能亲和力和多效性敏感性下降。有趣的是,HRP 主要导致了这些差异,而 LRP 则对新兴表位变体保持了定向和维持的功能反应。此外,与 HRP 相比,LRP 在自体和新兴表位变体刺激后诱导了更好的细胞周期进程和穿孔素上调。LRP 对新兴表位变体的 CD8(+) T 细胞反应保持了定量和定性特征,这为为什么 HLA-B5701 个体具有不同的 HIV-1 疾病进展风险提供了线索。